Title:
RECOMBINANT HUMAN PAPILLOMA VIRUS VACCINE COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/042830
Kind Code:
A1
Abstract:
Disclosed in the present invention are a recombinant human papilloma virus vaccine composition and a use thereof. Compared with other combinations of antigens and adjuvants, the new vaccine composition provided in the present invention has a more beneficial immune effect.
More Like This:
Inventors:
ZHOU CHENLIANG (CN)
LI JUNRUI (CN)
SONG YUJIAO (CN)
WEI JIAN (CN)
LIU GE (CN)
SHI LI (CN)
MO CHENGJUN (CN)
ZHANG ZHI (CN)
LI JUNRUI (CN)
SONG YUJIAO (CN)
WEI JIAN (CN)
LIU GE (CN)
SHI LI (CN)
MO CHENGJUN (CN)
ZHANG ZHI (CN)
Application Number:
PCT/CN2020/098205
Publication Date:
March 11, 2021
Filing Date:
June 24, 2020
Export Citation:
Assignee:
IMMUNE PATH BIOTECHNOLOGY SUZHOU CO LTD (CN)
International Classes:
A61K39/295
Foreign References:
| CN101622008A | 2010-01-06 | |||
| CN101622008A | 2010-01-06 | |||
| CN109701010A | 2019-05-03 |
Other References:
ZHAN NA, BINGSHUI XIU, GUOHUA WANG, KUN CHEN, GUANZHONG BAI, XIAOGUO SONG, CUIXIA ZHU, ZHENHUA DAI, XIQIN YANG, HEQIU ZHANG: "Enhancement of Humoral Immunity in the Mouse by Coupling CpG and Aluminium to the HCV Recombinant Immunogen", LETTERS IN BIOTECHNOLOGY, vol. 22, no. 6, 1 November 2011 (2011-11-01), pages 777 - 780, XP055789087, DOI: 10.3969 / j.issn.1009-0002.2011.06.006
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF: